Loading...
Estrogens, selective estrogen receptor modulators, and a selective estrogen receptor down-regulator inhibit endothelial production of tissue factor pathway inhibitor 1
BACKGROUND: Hormone therapy, oral contraceptives, and tamoxifen increase the risk of thrombotic disease. These compounds also reduce plasma content of tissue factor pathway inhibitor-1 (TFPI), which is the physiological inhibitor of the tissue factor pathway of coagulation. The current aim was to st...
Na minha lista:
Main Authors: | , , , , |
---|---|
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
BioMed Central
2006
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1609184/ https://ncbi.nlm.nih.gov/pubmed/17029634 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2261-6-40 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|